ACH (Accendra Health) 5-Year Yield-on-Cost %: 0.00 (As of Jul. 09, 2026)


ACH Accendra Health Inc ACH
57 GF Score
Price $3.17
GF Value $5.01
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Accendra Health 5-Year Yield-on-Cost %?

Accendra Health ACH -1.55% 57 5-Year Yield-on-Cost % is 0.00 as of Jul. 09, 2026. GuruFocus rates ACH with a GF Score™ of 57/100 and a GF Value™ of $5.01 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 69 Medical Distribution companies, Accendra Health ranks worse than 1449273.91% on this metric.

Accendra Health's yield on cost for the quarter that ended in Mar. 2026 was 0.00.


The historical rank and industry rank for Accendra Health's 5-Year Yield-on-Cost % or its related term are showing as below:


During the past 13 years, Accendra Health's highest Yield on Cost was 22.23. The lowest was 0.01. And the median was 1.67.


ACH's 5-Year Yield-on-Cost % is not ranked *
in the Medical Distribution industry.
Industry Median: 3.28
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Accendra Health  (NYSE:ACH) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Accendra Health 5-Year Yield-on-Cost % Related Terms


ACH vs FOCL, YI, COSM: 5-Year Yield-on-Cost % Comparison

For the Medical Distribution subindustry, Accendra Health's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Accendra Health 5-Year Yield-on-Cost % vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Accendra Health's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Accendra Health's 5-Year Yield-on-Cost % falls into.


ACH
57GF Score
Accendra Health Inc ACH
5-Year Yield-on-Cost % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Accendra Health 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Accendra Health is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 0.00 mean?
Accendra Health (ACH) has a 5-Year Yield-on-Cost % of 0.00 as of Jul. 09, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Accendra Health and its competitors. Over the past decade, Accendra Health's 5-Year Yield-on-Cost % has ranged from 0.01 to 22.23. According to the industry distribution chart, Accendra Health ranks #999999 out of 69 companies in the Medical Distribution industry.
Is Accendra Health's 5-Year Yield-on-Cost % too high?
Accendra Health's current 5-Year Yield-on-Cost % is 0.00. Over the past 10 years, this metric has ranged from a low of 0.01 to a high of 22.23. Based on the distribution chart, Accendra Health ranks #999999 out of 69 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Accendra Health has a GF Score™ of 57/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Accendra Health's 5-Year Yield-on-Cost % compare to FOCL and YI?
According to the Medical Distribution industry distribution chart, Accendra Health ranks #999999 out of 69 companies for 5-Year Yield-on-Cost %. This places Accendra Health in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 3.28. Historically, Accendra Health's own 5-Year Yield-on-Cost % has ranged from 0.01 to 22.23 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Distribution company?
The median 5-Year Yield-on-Cost % among Medical Distribution companies is 3.28, based on 69 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Accendra Health and its competitors. For the Medical Distribution industry, the median 5-Year Yield-on-Cost % is 3.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Accendra Health's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accendra Health stock overvalued right now?
Based on GuruFocus' analysis, Accendra Health (ACH) is currently considered Possible Value Trap. The stock's GF Value™ is $5.01, compared to a current price of $3.17 — trading 36.7% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. Accendra Health's overall GF Score™ is 57/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Accendra Health (ACH), the current 5-Year Yield-on-Cost % is 0.00 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Accendra Health (ACH) Overvalued in 2026?

Based on GuruFocus' analysis, Accendra Health stock appears to be undervalued. The current stock price of $3.17 is trading 36.7% below its estimated GF Value™ of $5.01. GuruFocus considers Accendra Health to be Possible Value Trap.

Key valuation signals for ACH:

  • 5-Year Yield-on-Cost %: 0.00
  • GF Value™: $5.01 vs. price of $3.17 (36.7% below fair value)
  • GF Score™: 57/100 with 7 warning signs

No single metric tells the full story. See the ACH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Accendra Health Business Description

Other Exchanges 6OM:Germany
Address 10900 Nuckols Road, Suite 400, Glen Allen, VA, USA, 23060
Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.
57GF Score

Get the complete analysis for ACH

5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.17
Price
$5.01
GF Value